Confirmed Control Announced Transaction verified BiopharmaceuticalsDermatologyDermatology SolutionsDermatology Therapeutics
Dermira acquired by Eli Lilly
Eli Lilly agreed to acquire Dermira, a dermatology solutions brand on Jan 10, 2020. FundComb records estimated consideration of USD 1. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Dermira
- Acquirer
- Eli Lilly
- Seller
- -
- Announced
- 2020-01-10
- Geography
- -
- Tags
- BiopharmaceuticalsDermatologyDermatology SolutionsDermatology Therapeutics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
USD 1
Transaction value | USD
Basis: FundComb estimate
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 1 transaction value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
Source summary
No public source summary has been published for this transaction yet.